跳至主要内容
临床试验/NCT00576849
NCT00576849已完成4 期

Phase 4 Study of a Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients

Klinikum Ludwigshafen1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2007年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
The primary endpoint of the study is postoperative renal function

研究概览

简要总结

A total balanced fluid replacement strategy is a promising concept for correcting hypovolemia. The effects of a balanced fluid management including a new balanced hydroxyethylstarch (HES) in elderly cardiac surgery patients will be studied.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
80 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged >80 years

排除标准

  • Chronic kidney dysfunction requiring dialysis
  • Myocardial infarction within the previous 3 weeks
  • Liver insufficiency

研究组 & 干预措施

A

Experimental

Total balanced volume replacement regimen consisting of a balanced HES 130/0.42 plus a balanced crystalloid

干预措施: Balanced HES 130/0.42 (Drug)

B

Active Comparator

Conventional volume replacement strategy consisting of 6% HES 130/0.4 prepared in saline solution plus Ringer's lactate

干预措施: 6% HES 130/0.4 prepared in saline solution (Drug)

结局指标

主要结局

The primary endpoint of the study is postoperative renal function

时间窗: 28 days

次要结局

  • Other organ function (myocardial function, endothelial function, degree of inflammation)(Postoperative period)

研究者

发起方
Klinikum Ludwigshafen
申办方类型
Other

研究点 (1)

Loading locations...

相似试验